The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2330 THE ROLE OF TRANSFORMING GROWTH FACTOR<br />
BETA 1 (TGF-β1) IN TOBACCO-SMOKE-INDUCED<br />
LUNG INJURIES.<br />
L. L. Hoang and K. E. Pinkerton. Center for Health and the Environment,<br />
University <strong>of</strong> California, Davis, Davis, CA.<br />
Rationale: Chronic obstructive pulmonary disease (COPD) is the fourth leading<br />
cause <strong>of</strong> death in the United States with 80-90% <strong>of</strong> all COPD cases attributed to<br />
smoking. Clinical studies have shown strong correlations between the progression<br />
<strong>of</strong> COPD and small airway remodeling indicated by increased small airway wall<br />
thickness, airway inflammation, mucus hypersecretion, and increased airway<br />
smooth muscle mass. However, the mechanism <strong>of</strong> small airway remodeling in<br />
COPD remains elusive. Previous clinical research demonstrated increased TGF-β1<br />
expression in the lungs <strong>of</strong> COPD patients. TGF-β1 could be critical to small airway<br />
remodeling in COPD due to its ability to regulate both immune cells and airway<br />
structural cells. <strong>The</strong>refore, we used TGF-β1+/- mice exposed to tobacco smoke to<br />
study the functions <strong>of</strong> TGF-β1 in tobacco smoke induced lung injury. Methods:<br />
TGF-β1+/- mice were exposed to tobacco smoke at 150 mg/m3 for 6 hours/day, 5<br />
days/week for one month. Lungs were lavaged for analysis <strong>of</strong> cell viability, number<br />
and cell differential. Tracheas and lung lobes were frozen for qRT-PCR experiments.<br />
Results: Compared to wild type mice, TGF-β1+/- mice exhibited an increase<br />
in inflammatory cells recovered in the bronchoalveolar lavage fluid following<br />
smoke exposure. TGF-β1+/- mice exposed to tobacco smoke also showed a reduction<br />
in tracheal Muc5b mRNA expression. Smooth muscle alpha actin mRNA expression<br />
was also found to be elevated in the lungs <strong>of</strong> TGF-β1+/- mice following<br />
smoke exposure. Conclusions: We conclude TGF-β1 may protect the lungs from<br />
tobacco smoke induced pulmonary inflammation. TGF-β1 may also play a critical<br />
role to regulate mucus production and decrease airway smooth muscle hypertrophy<br />
during tobacco smoke exposure. Funded by: NIEHS (ES 011634 and ES013932)<br />
and TRDRP (18XT-0154)<br />
2331 RESPIRATORY AND SYSTEMIC RESPONSES TO URBAN<br />
SUMMER AND WINTER SUB-MICRON FINE AND<br />
ULTRAFINE PARTICULATE MATTER.<br />
L. E. Plummer 1 , C. M. Carosino 1 , K. J. Bein 2 , A. S. Wexler 2 and K. E.<br />
Pinkerton 1 . 1 Center for Health and the Environment, University <strong>of</strong> California, Davis,<br />
CA and 2 Civil and Environmental Engineering, University <strong>of</strong> California, Davis, CA.<br />
Understanding seasonal impacts on adverse respiratory and systemic health effects<br />
can lead to more effective targeting <strong>of</strong> sources for improved control <strong>of</strong> particulate<br />
matter (PM) pollution, a concern for California’s San Joaquin Valley (SJV).<br />
Toxicological evaluation <strong>of</strong> PM is critical in providing biological relevance for observed<br />
effects. <strong>The</strong>refore, we tested the pro-inflammatory potential <strong>of</strong> SJV summer<br />
and winter PM sub-micron fine (SMF) and ultrafine (UF) from urban Fresno, CA<br />
in the lungs and blood <strong>of</strong> healthy male Balb/C mice. Inflammatory cell pr<strong>of</strong>ile and<br />
cytotoxicity were measured 24 hours after intratracheal instillation <strong>of</strong> 25, 50 and<br />
100 μg <strong>of</strong> PM/mouse. PM size distributions and oxidative potential were characterized<br />
using dynamic light scattering (DLS) and the cell-free dithiothreitol (DTT)<br />
assay, respectively. For all doses and both size-fractions, winter PM induced significantly<br />
greater acute pulmonary inflammation than equivalent doses <strong>of</strong> summer PM<br />
and was characterized by a robust, dose-dependent total leukocyte, neutrophil and<br />
lymphocyte influx. On an equal mass basis, winter SMF PM was more pro-inflammatory<br />
than winter UF PM however this difference was not statistically significant.<br />
Dose-dependent increases in circulating inflammatory cells and hematologic<br />
changes did not attain statistical significance. Particle measurements confirmed efficient<br />
dispersion and higher oxidative potential <strong>of</strong> winter versus summer PM for<br />
both size fractions. Pro-inflammatory potential <strong>of</strong> Fresno PM was significantly influenced<br />
by size and season. <strong>The</strong> relative toxicity within the lung was ranked: winter<br />
SMF > winter UF > summer SMF > summer UF. <strong>The</strong> potency <strong>of</strong> winter PM<br />
may be associated with observed DTT activity <strong>of</strong> winter SMF and UF PM. <strong>The</strong>se<br />
studies are the initial results for source-oriented particle sampling and toxicity testing<br />
designed to elucidate key source contributors to PM toxicity. Funded by<br />
CARB/EPRI.<br />
2332 PARTICLE UPTAKE OF GASEOUS AIR TOXICS<br />
MODIFIES OBSERVED TOXICITY OF PM.<br />
S. M. Ebersviller1 , K. Lichtveld1 , J. Zavala1 , Y. Lin1 , K. G. Sexton1 , I. Jaspers1, 2<br />
and H. Jeffries1 . 1Environment Sciences . and Engineering, UNC-CH, Chapel Hill,<br />
NC and 2CEMALB, UNC-CH, Chapel Hill, NC.<br />
<strong>The</strong> National Research Council has called for efforts toward determining whether<br />
‘effect modification’ occurs between particulate matter (PM) and gases that surround<br />
it in the environment. Researchers have long known that gases and particles<br />
interact via dynamic processes in the atmosphere. What has been unclear to this<br />
point is if these interactions affect the actual toxicity <strong>of</strong> each phase. To investigate<br />
these processes, a series <strong>of</strong> experiments was conducted in an outdoor smog chamber<br />
capable <strong>of</strong> mimicking the ambient environment. In vitro cell cultures were exposed<br />
to the gas and particle phases <strong>of</strong> air mixtures using gas and particle exposure systems<br />
coupled directly to the chamber, thereby allowing exposures to occur without sampling<br />
artifacts. Mineral oil aerosol (MOA) acted as a non-toxic analog to ambient<br />
PM, as it possesses representative complexity in composition but lacks any inherent<br />
toxicity that may interfere with observations. A mixture <strong>of</strong> 55 compounds was injected<br />
into the chamber to represent a typical urban atmosphere. Exposures to the<br />
fresh chamber contents were performed both with and without MOA present.<br />
Chamber contents were allowed to react in natural sunlight for one day and exposures<br />
were repeated, again with and without MOA. As observed in previous work,<br />
the fresh mixture induced no response from exposed cells with either in vitro<br />
method, while there was a dramatic increase in response from cells exposed to the<br />
aged mixture using the gas-only system. For the system in which there was no PM<br />
present, there was no response from the cells exposed with the particle-only<br />
method. When MOA was added to the chamber after sundown, however, there was<br />
more than 6X the inflammatory response than was observed for any controls or the<br />
fresh exposure. As the MOA was added after sunset, the only source this increase in<br />
toxicity was the uptake <strong>of</strong> toxic species from the air surrounding the aerosol. <strong>The</strong>se<br />
results together provide clear pro<strong>of</strong> that ‘effect modification’ can, and is likely to,<br />
occur in the ambient environment.<br />
2333 CONTRIBUTIONS OF TRPV1 AND TRPM8 TO LUNG<br />
INJURY BY COAL FLY ASH.<br />
C. A. Reilly, C. E. Deering-Rice, M. E. Johansen, J. K. Roberts, E. G. Romero,<br />
J. M. Veranth and G. S. Yost. Pharmacology and <strong>Toxicology</strong>, University <strong>of</strong> Utah, Salt<br />
Lake City, UT.<br />
Acute and long-term heath deficits are correlated with exposure to environmental<br />
particulate pollutants (PM). However, the molecular sensors that detect, differentiate,<br />
and respond to PM are <strong>of</strong>ten unknown. TRPV1 has been implicated as a sensor<br />
<strong>of</strong> PM and activation <strong>of</strong> TRPV1 has been correlated with inflammation, cell<br />
death, and altered cardiopulmonary function. This research investigated TRPV1<br />
activation using a series <strong>of</strong> prototype PM, established a role for TRPV1 in pulmonary<br />
injury following instillation <strong>of</strong> PM into lungs <strong>of</strong> mice, and identified<br />
mechanisms <strong>of</strong> TRPV1 activation. A screen <strong>of</strong> TRPV1 activation by 8 prototype<br />
PM identified a coal fly ash PM (CFAm), silica, and diesel exhaust PM (DEP) as<br />
agonists. CFAm did not activate TRPA1, V3, or V4, but activated TRPM8. Like<br />
capsaicin, CFAm induced the expression <strong>of</strong> CXCL-1/KC, CXCL-2/MIP-2α and<br />
IL-6 in distal airways, and pro-apoptotic GADD153 in alveoli, consistent with<br />
lung injury in C57Bl/6 mice. CFAm activated cultured mouse DRG neurons and<br />
induced the expression <strong>of</strong> IL-6, IL-8, and GADD153 in primary human bronchial<br />
epithelial (NHBE) cells, all <strong>of</strong> which were attenuated by the TRPV1 antagonist<br />
LJO-328. Accordingly, CFAm-induced lung injury in TRPV1-/- mice was reduced.<br />
Calcium flux in TRPV1 over-expressing human bronchial epithelial cells by CFAm<br />
was inhibited by co-treatment by LJO-328 and by inhibition <strong>of</strong> cell surface TRPV1<br />
using EGTA and ruthenium red. Responses were also exacerbated by enriching<br />
TRPV1 at the cell surface. TRPV1 activation was attributable to the solid core fraction<br />
<strong>of</strong> CFAm and occurred through an interaction with residues adjacent to the<br />
pore-loop segment <strong>of</strong> TRPV1. <strong>The</strong>se data show an additive role for sensory nerve<br />
and non-neuronal TRPV1 in mediating lung injury by a model PM and reveal a<br />
novel mechanism <strong>of</strong> activation involving PM contact with cell surface residues that<br />
may also occur for other PM that activate TRPV1. Additionally, TRPM8 may also<br />
contribute to lung injury by this PM. Support: ES017431 and HL069813.<br />
2334 ACTIVATION OF HUMAN TRPA1 BY DIESEL EXHAUST<br />
PARTICLES (DEP): ASSOCIATION WITH LUNG INJURY.<br />
C. Deering-Rice, E. G. Romero, J. M. Veranth, G. S. Yost and C. A. Reilly.<br />
Pharmacology/<strong>Toxicology</strong>, University <strong>of</strong> Utah, Salt Lake City, UT.<br />
Inhalation exposure to environmental particulate air pollutants (PM) is correlated<br />
with a number <strong>of</strong> adverse health effects in humans. However, the molecular “sensors”<br />
that detect, differentiate, and initiate deleterious responses to PM that likely<br />
culminate as compromised health are not known. TRPV1 and TRPA1 orchestrate<br />
responses to a number <strong>of</strong> prototype respiratory toxicants including capsaicin,<br />
acrolein, and crotonaldehyde. <strong>The</strong> hypothesis <strong>of</strong> this study was that TRPA1, and<br />
not TRPV1, would be activated by specific forms <strong>of</strong> environmental PM in vitro<br />
and that activation in vivo would result in lung injury. A screen <strong>of</strong> 6 prototype PM<br />
revealed that diesel exhaust PM (DEP) activated TRPA1 and that bioactivity was<br />
retained in ethanol extracts. Ethanol extracts <strong>of</strong> DEP failed to activate TRPM8, V1,<br />
V3 and V4. <strong>The</strong> extract induced calcium flux in isolated mouse DRG neurons sensitive<br />
to the prototype TRPA1 agonist AITC and were abolished by co-treatment<br />
SOT 2011 ANNUAL MEETING 501